Problems › What a Management Consultant Costs › B2B SaaS
You are not buying analysis. You are buying a staffing mix whose size and duration are set by how many cohorts must be rebuilt around net revenue retention and CAC payback. What makes this harder for B2B SaaS companies is structural: growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics. Any credible answer therefore has to hold net revenue retention and CAC payback in the same view, which is exactly where most internal analysis stops because the two live in different systems.
You are not buying analysis. You are buying a staffing mix whose size and duration are set by how many cohorts must be rebuilt around net revenue retention and CAC payback. What makes this harder for B2B SaaS companies is structural: growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics. Any credible answer therefore has to hold net revenue retention and CAC payback in the same view, which is exactly where most internal analysis stops because the two live in different systems.
Fees arrive as one project number for a B2B SaaS operator, yet that number is produced by a fixed ratio of partner time, manager oversight, and junior staff running the data pulls. The partner rate appears in early conversations; the actual invoice is driven by how many analysts are assigned to segment ACV and gross-margin tables. The ratio stays constant even when the founder asks only for a single decision on the 60 % of revenue with the weakest economics.
The same ratio explains why the team that presented the land-and-expand case is rarely the team that stays after week two. It explains why the engagement length tracks the number of retention cohorts examined rather than the difficulty of the churn pattern itself. And it explains why tightening the question to one segment’s CAC payback saves more than any discussion of rates, because each removed workstream directly reduces the number of analysts required.
The larger cost sits inside the company: the finance lead must supply ARR by segment and update the payback model each week, the growth lead must prepare the data for every steering meeting, and the CEO must review draft scenarios on land-and-expand before they reach the board. These hours accumulate across the full engagement and are rarely budgeted in advance.
The relevant test is therefore not the fee against another firm’s fee. It is the fee against the revenue decision at stake. When the question concerns which segment should receive investment to lift overall net revenue retention, the cost of the pyramid must be weighed against the ARR impact of that choice; when the question is narrower, the same pyramid becomes the more expensive route.
These three together are the signature. One on its own usually points somewhere else.
✓ The proposal states a single total but does not list how many analysts will run retention and payback models by ACV tier.
✓ The scope is locked before anyone has written the one-sentence question about which segment’s economics must improve.
✓ No one has added up the hours the internal finance and growth leads will spend supplying cohort data and attending reviews.
The move that usually makes it worse. Negotiating the blended rate instead of removing a workstream on low-performing segments, which trims only a fraction of a fee set by the number of retention and payback analyses required.
It is for you if you run or finance a B2B SaaS company and the proposal quotes a total and will not break out the team composition. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a B2B SaaS company. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.
Excerpt from a real Percision run · Cost Reduction & Efficiency · sample company profile
The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.
| Investment required | $3.0-4.2 M total over 36 months |
| Expected return | Base case 3.8× cash-on-cash within 36 months |
| Revenue, year 1 | $47.8-49.2 M ARR |
| Revenue, year 2 | $51.5-54.0 M ARR |
| Revenue, year 3 | $56.0-60.0 M ARR |
| Exit criteria | Strategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Corporate Strategy & Transformation, one of 29 engagements the platform runs. For B2B SaaS companies it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Partly brand and partly the pyramid, but mostly risk transfer. A board that has bought a recommendation from a well-known firm has a defensible position if it goes wrong, and that defensibility is a real product with a real price. If nobody needs to be protected — an owner-managed business deciding its own capital — you are paying for insurance you will never claim on.
Cheaper, yes; equivalent, sometimes. An experienced independent at £1,000 a day often produces better judgement than a junior team at three times the blended cost, because judgement is what you are short of. What they cannot supply is throughput — one person cannot interview forty people in three weeks. Match it to whether your constraint is thinking or hands.
Compare like for like: the software replaces the analysis, not the delivery, the relationship, or the accountability. A fair comparison is a subscription against the diagnostic phase of an engagement — typically £75k–£250k — and not against the whole programme. Where the diagnosis is genuinely all you needed, the gap is very large. Where it is not, the subscription does not close it.
Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית